Guidance downgrade
The latest news about Guidance downgrade: headlines, AI summaries and the full story from every source.
- Paysafe Shares Drop 28% Following Q3 Earnings Miss and Lowered Guidance
- Paysafe Reports Q3 Earnings Miss and Lowers FY2026 Revenue Guidance
- Grocery Outlook (GO) Lowers Profit Guidance Due to Promotional Pricing and Rising Costs
- EVgo Reports Q3 Revenue Miss and Lowers 2026 Guidance
- Wix Shares Decline Following Lowered Free Cash Flow Margin Outlook
- Harvard Bioscience Reports Q3 Revenue Growth Amid Lowered FY2026 Outlook
- Inspired Entertainment Reports Q3 Results Amid Revenue Decline and Revised Guidance
- Jain Impex (JYNT) Reports Q3 Earnings Miss and Lowers System-Wide Sales Guidance
- Prestige Healthcare Reports Q2 2027 Revenue Growth Driven by Acquisitions Amid Eye Care Production Volatility
- Gildan Activewear Lowers FY26 Outlook Following Third Quarter Earnings Miss
- Veracyte Shares Plunge Following Lowered Full-Year Guidance and Analyst Downgrade
- Array Technologies Reports Q3 Earnings Miss and Lowers Full Year 2026 Revenue Guidance
- NexPoint Residential Reports Q3 2026 Earnings Miss and Lowers Full-Year Guidance
- XPLR Infrastructure Reports Q3 Earnings Miss and Lowers 2026 Financial Outlook
- Camping World Reports Q3 Miss on Earnings and Revenue Amid Weakening RV Demand
- Farmland Partners Reports Q3 2026 Net Loss Amid Asset Impairments and Legal Reserves
- Eldorado Gold Reports Q3 2026 Revenue Growth Amidst Production Guidance Downgrades
- Xerox Reports Q3 2026 Results with Lowered Guidance Amidst Market Headwinds
- Class Action Lawsuit Filed Against Tigo Energy Following Revenue Miss and Guidance Downgrade
- Carrier Global Shares Drop Following $3.1 Billion Impairment Charge and Lowered Earnings Outlook
- Community Health Systems Shares Fall After Q3 Earnings Miss and Lowered 2026 Guidance
- Boston Scientific Reports Q3 2026 Results Impacted by Cybersecurity Disruption and China Pricing Pressures
- Noble Plc Shares Fall Following Third Quarter Earnings Miss and Lowered EBITDA Guidance
- Abbott Laboratories Shares Decline Following Lowered 2026 Growth Outlook
- Lululemon Cuts Guidance Amid Brand Challenges and Sales Declines
- Lennox Reports Missed EPS and Revenue in Q2